193 related articles for article (PubMed ID: 23467026)
1. The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia.
Hariri F; Arguello M; Volpon L; Culjkovic-Kraljacic B; Nielsen TH; Hiscott J; Mann KK; Borden KL
Leukemia; 2013 Oct; 27(10):2047-55. PubMed ID: 23467026
[TBL] [Abstract][Full Text] [Related]
2. Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML.
Volk A; Li J; Xin J; You D; Zhang J; Liu X; Xiao Y; Breslin P; Li Z; Wei W; Schmidt R; Li X; Zhang Z; Kuo PC; Nand S; Zhang J; Chen J; Zhang J
J Exp Med; 2014 Jun; 211(6):1093-108. PubMed ID: 24842373
[TBL] [Abstract][Full Text] [Related]
3. Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin.
Assouline S; Culjkovic B; Cocolakis E; Rousseau C; Beslu N; Amri A; Caplan S; Leber B; Roy DC; Miller WH; Borden KL
Blood; 2009 Jul; 114(2):257-60. PubMed ID: 19433856
[TBL] [Abstract][Full Text] [Related]
4. Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis.
Topisirovic I; Guzman ML; McConnell MJ; Licht JD; Culjkovic B; Neering SJ; Jordan CT; Borden KL
Mol Cell Biol; 2003 Dec; 23(24):8992-9002. PubMed ID: 14645512
[TBL] [Abstract][Full Text] [Related]
5. [Expression of eIF4E in patients with leukemia and its clinical significance].
Zhu LF; Chen XJ; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):1-6. PubMed ID: 23484680
[TBL] [Abstract][Full Text] [Related]
6. [Overexpression of eIF4E gene in acute myeloid leukemia and its relation with disease progression].
Jiang YD; Lu YH; Chen SH; Zhu KE; Zhang XL; Yu Z; Zhong J; Zhang T; Luo GX; Chen J; Pan HY; Li Y; Qin LA; Li YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):296-9. PubMed ID: 23628019
[TBL] [Abstract][Full Text] [Related]
7. [Expression of NF-kappaB mRNA in acute myeloid leukemia].
Liu M; Wei XD; Lü XD; Fan RH; Yin QS; Zhou J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):359-62. PubMed ID: 20416168
[TBL] [Abstract][Full Text] [Related]
8. The eukaryotic translation initiation factor eIF4E reprograms alternative splicing.
Ghram M; Morris G; Culjkovic-Kraljacic B; Mars JC; Gendron P; Skrabanek L; Revuelta MV; Cerchietti L; Guzman ML; Borden KLB
EMBO J; 2023 Apr; 42(7):e110496. PubMed ID: 36843541
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.
Pettersson F; Del Rincon SV; Miller WH
Expert Opin Ther Targets; 2014 Sep; 18(9):1035-48. PubMed ID: 25004955
[TBL] [Abstract][Full Text] [Related]
10. Targeting of phospho-eIF4E by homoharringtonine eradicates a distinct subset of human acute myeloid leukemia.
Zhou H; Xu RZ; Gu Y; Shi PF; Qian S
Leuk Lymphoma; 2020 May; 61(5):1084-1096. PubMed ID: 29334312
[TBL] [Abstract][Full Text] [Related]
11. Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
Kosciuczuk EM; Saleiro D; Platanias LC
Cytokine; 2017 Jan; 89():116-121. PubMed ID: 27094611
[TBL] [Abstract][Full Text] [Related]
12. The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance.
Rushworth SA; Zaitseva L; Murray MY; Shah NM; Bowles KM; MacEwan DJ
Blood; 2012 Dec; 120(26):5188-98. PubMed ID: 23077289
[TBL] [Abstract][Full Text] [Related]
13. IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production.
Kim MS; Kang JW; Jeon JS; Kim JK; Kim JW; Hong J; Yoon DY
Oncotarget; 2015 Dec; 6(38):40747-61. PubMed ID: 26516703
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of translation eukaryotic initiation factor 4E in nucleophosmin 1 haploinsufficient cells results in changes in CCAAT enhancer-binding protein α activity: implications in myelodysplastic syndrome and acute myeloid leukemia.
Khanna-Gupta A; Abayasekara N; Levine M; Sun H; Virgilio M; Nia N; Halene S; Sportoletti P; Jeong JY; Pandolfi PP; Berliner N
J Biol Chem; 2012 Sep; 287(39):32728-37. PubMed ID: 22851180
[TBL] [Abstract][Full Text] [Related]
15. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.
Grosjean-Raillard J; Tailler M; Adès L; Perfettini JL; Fabre C; Braun T; De Botton S; Fenaux P; Kroemer G
Oncogene; 2009 Feb; 28(8):1099-109. PubMed ID: 19079347
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia.
Khalife J; Radomska HS; Santhanam R; Huang X; Neviani P; Saultz J; Wang H; Wu YZ; Alachkar H; Anghelina M; Dorrance A; Curfman J; Bloomfield CD; Medeiros BC; Perrotti D; Lee LJ; Lee RJ; Caligiuri MA; Pichiorri F; Croce CM; Garzon R; Guzman ML; Mendler JH; Marcucci G
Leukemia; 2015 Oct; 29(10):1981-92. PubMed ID: 25971362
[TBL] [Abstract][Full Text] [Related]
18. Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts.
Baumgartner B; Weber M; Quirling M; Fischer C; Page S; Adam M; Von Schilling C; Waterhouse C; Schmid C; Neumeier D; Brand K
Leukemia; 2002 Oct; 16(10):2062-71. PubMed ID: 12357358
[TBL] [Abstract][Full Text] [Related]
19. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic translation initiation factor 4E activity is modulated by HOXA9 at multiple levels.
Topisirovic I; Kentsis A; Perez JM; Guzman ML; Jordan CT; Borden KL
Mol Cell Biol; 2005 Feb; 25(3):1100-12. PubMed ID: 15657436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
